The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

While patients initially start taking oral drugs like levodopa and carbidopa ... The latter is administered as a continuous infusion using a portable pump, via a percutaneous jejunostomy tube ...

Hospitals must start using “smart” intravenous (IV) infusion technology to its full potential if they are to prevent dangerous drug errors, University of Manchester researchers have found. ‘Smart ...

The wearable pump is designed to provide a continuous subcutaneous infusion of Supernus’ apomorphine (Apokyn). The drug is intended for patients experiencing “off” periods, where medication ...

The infusion, known as foslevodopa-foscarbidopa ... For the best stories in your inbox, click here. A wearable drug pump that delivers medication to Parkinson’s patients 24 hours a day to ...

It is used to deliver drugs that replace the dopamine ... continuous subcutaneous infusion of apomorphine delivered using the Apo-go pump, which has been available in Europe for around 20 years.

through an infusion pump. Otsuka and Lundbeck are seeking another indication for brexpiprazole, an atypical antipsychotic, combining it with sertraline, a selective serotonin reuptake inhibitor ...